Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis

Arthritis and Rheumatism

Volumn 43, Issue 10, 2000, Pages 2230-2239

  Jelaska, Ante ^a   Korn, Joseph H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FAS ANTIGEN; MESSENGER RNA; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL SELECTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ACTINS; ADULT; AGED; ANTIBODIES, MONOCLONAL; APOPTOSIS; COLLAGEN; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PHENOTYPE; SCLERODERMA, SYSTEMIC; SKIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0033788161     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8     Document Type: Article

References (53)

1. Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization
2. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients
3. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma)
4. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblast
5. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts
6. Mononuclear cell modulation of connective tissue function: Suppression of fibroblast growth by stimulation of endogenous prostaglandin production
7. Fibroblast heterogeneity: Clonal selection of fibroblasts as a model for fibrotic disease
8. Clonal heterogeneity in the fibroblast response to mononuclear cell derived mediators
9. Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts
10. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts
11. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
12. Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts
13. Skin distribution and differential expression of transforming growth factor β1 and β2
14. Transcription and expression of transforming growth factor type β in the skin of progressive systemic sclerosis: A mediator of fibrosis?
15. Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders
16. Elevated levels of platelet derived growth factor and transforming growth factor-β1 in bronchoalveolar lavage fluid from patients with scleroderma
17. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing
18. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β
19. The transforming growth factor-β family
20. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
21. Morphological and immunochemical differences between keloid and hypertrophic scar
22. Myofibroblasts and the progression of diabetic nephropathy
23. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis
24. Phenotypic change in portal fibroblasts in biliary fibrosis
25. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1
26. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
27. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: Differences between foreskin and adult fibroblasts
28. Cloning and characterization of five overlapping cDNAs specific for the human proα1(I) collagen chain
29. Detection of messenger RNA by in situ hybridization
30. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
31. Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
32. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity
33. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor
34. Immunohistochemical localization of intracellular and extracellular associated TGF β in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon
35. Immunocytochemical localization and serologic detection of transforming growth factor β1: Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon
36. Transforming growth factor-β1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma
37. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens
38. Local production of TGFβ1 inhibits cerebral edema, enhances TNF-α induced apoptosis and improves survival in a murine glioma model
39. Endogenous expression of transforming growth factor β1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model
40. NGF exhibits a pro-apoptotic activity for human vascular smooth muscle cells that is inhibited by TGFβ1
41. Transforming growth factor-β1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells
42. Transforming growth factor β1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells
43. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1
44. Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGFβ1 and bcl-2 expression
45. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
46. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction
47. Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts
48. Rat alveolar myofibroblasts acquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis
49. Growth regulation in scleroderma fibroblasts: Increased response to transforming growth factor-β1
50. Different effects of basic fibroblast growth factor and transforming growth factor-β on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts
51. Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts
52. Transforming growth factor-β: Selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis
53. Collagen synthesis by human liver (myo)fibroblasts in culture: Evidence for a regulatory role of IL-1β, IL-4, TGFβ and IFN-γ